609 related articles for article (PubMed ID: 28846767)
1. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
[TBL] [Abstract][Full Text] [Related]
2. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.
Gleason CE; Dowling NM; Wharton W; Manson JE; Miller VM; Atwood CS; Brinton EA; Cedars MI; Lobo RA; Merriam GR; Neal-Perry G; Santoro NF; Taylor HS; Black DM; Budoff MJ; Hodis HN; Naftolin F; Harman SM; Asthana S
PLoS Med; 2015 Jun; 12(6):e1001833; discussion e1001833. PubMed ID: 26035291
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
[TBL] [Abstract][Full Text] [Related]
4. Effects of different hormone therapies on breast pain in recently postmenopausal women: findings from the Mayo Clinic KEEPS breast pain ancillary study.
Files JA; Miller VM; Cha SS; Pruthi S
J Womens Health (Larchmt); 2014 Oct; 23(10):801-5. PubMed ID: 25268853
[TBL] [Abstract][Full Text] [Related]
5. Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial.
El Khoudary SR; Venugopal V; Manson JE; Brooks MM; Santoro N; Black DM; Harman M; Naftolin F; Hodis HN; Brinton EA; Miller VM; Taylor HS; Budoff MJ
Menopause; 2020 Mar; 27(3):255-262. PubMed ID: 32015261
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).
Cintron D; Lahr BD; Bailey KR; Santoro N; Lloyd R; Manson JE; Neal-Perry G; Pal L; Taylor HS; Wharton W; Naftolin F; Harman SM; Miller VM
Menopause; 2018 Feb; 25(2):145-153. PubMed ID: 28832429
[TBL] [Abstract][Full Text] [Related]
7. Effects of hormones on skin wrinkles and rigidity vary by race/ethnicity: four-year follow-up from the ancillary skin study of the Kronos Early Estrogen Prevention Study.
Owen CM; Pal L; Mumford SL; Freeman R; Isaac B; McDonald L; Santoro N; Taylor HS; Wolff EF
Fertil Steril; 2016 Oct; 106(5):1170-1175.e3. PubMed ID: 27393520
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study.
Crandall CJ; Hovey KM; Andrews C; Cauley JA; Stefanick M; Shufelt C; Prentice RL; Kaunitz AM; Eaton C; Wactawski-Wende J; Manson JE
Menopause; 2017 Oct; 24(10):1145-1153. PubMed ID: 28697036
[TBL] [Abstract][Full Text] [Related]
9. Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition.
Kantarci K; Lowe VJ; Lesnick TG; Tosakulwong N; Bailey KR; Fields JA; Shuster LT; Zuk SM; Senjem ML; Mielke MM; Gleason C; Jack CR; Rocca WA; Miller VM
J Alzheimers Dis; 2016 May; 53(2):547-56. PubMed ID: 27163830
[TBL] [Abstract][Full Text] [Related]
10. Lessons from KEEPS: the Kronos Early Estrogen Prevention Study.
Miller VM; Taylor HS; Naftolin F; Manson JE; Gleason CE; Brinton EA; Kling JM; Cedars MI; Dowling NM; Kantarci K; Harman SM
Climacteric; 2021 Apr; 24(2):139-145. PubMed ID: 32880220
[TBL] [Abstract][Full Text] [Related]
11. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.
Nijland EA; Weijmar Schultz WC; Nathorst-Boös J; Helmond FA; Van Lunsen RH; Palacios S; Norman RJ; Mulder RJ; Davis SR;
J Sex Med; 2008 Mar; 5(3):646-56. PubMed ID: 18304284
[TBL] [Abstract][Full Text] [Related]
12. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial.
Harman SM; Black DM; Naftolin F; Brinton EA; Budoff MJ; Cedars MI; Hopkins PN; Lobo RA; Manson JE; Merriam GR; Miller VM; Neal-Perry G; Santoro N; Taylor HS; Vittinghoff E; Yan M; Hodis HN
Ann Intern Med; 2014 Aug; 161(4):249-60. PubMed ID: 25069991
[TBL] [Abstract][Full Text] [Related]
13. Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women.
Decensi A; Omodei U; Robertson C; Bonanni B; Guerrieri-Gonzaga A; Ramazzotto F; Johansson H; Mora S; Sandri MT; Cazzaniga M; Franchi M; Pecorelli S
Circulation; 2002 Sep; 106(10):1224-8. PubMed ID: 12208797
[TBL] [Abstract][Full Text] [Related]
14. Plasma orexin A levels in recently menopausal women during and 3 years following use of hormone therapy.
Cintron D; Beckman JP; Bailey KR; Lahr BD; Jayachandran M; Miller VM
Maturitas; 2017 May; 99():59-65. PubMed ID: 28364870
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
Ziaei S; Moghasemi M; Faghihzadeh S
Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
[TBL] [Abstract][Full Text] [Related]
16. Hormone therapy for sexual function in perimenopausal and postmenopausal women.
Nastri CO; Lara LA; Ferriani RA; Rosa-E-Silva AC; Figueiredo JB; Martins WP
Cochrane Database Syst Rev; 2013 Jun; (6):CD009672. PubMed ID: 23737033
[TBL] [Abstract][Full Text] [Related]
17. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.
Hilditch JR; Lewis J; Ross AH; Peter A; van Maris B; Franssen E; Charles J; Norton P; Dunn EV
Maturitas; 1996 Jul; 24(3):177-84. PubMed ID: 8844631
[TBL] [Abstract][Full Text] [Related]
19. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.
LaCroix AZ; Chlebowski RT; Manson JE; Aragaki AK; Johnson KC; Martin L; Margolis KL; Stefanick ML; Brzyski R; Curb JD; Howard BV; Lewis CE; Wactawski-Wende J;
JAMA; 2011 Apr; 305(13):1305-14. PubMed ID: 21467283
[TBL] [Abstract][Full Text] [Related]
20. Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women.
Rabbani LE; Seminario NA; Sciacca RR; Chen HJ; Giardina EG
J Am Coll Cardiol; 2002 Dec; 40(11):1991-9. PubMed ID: 12475460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
